Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBL.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.18.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.23.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.568NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.13 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.372NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.634NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.37.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.630NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.360NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.578NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.544NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.425NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used